Advisor Group Holdings, Inc. Cocrystal Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $54 - $720	-200 Reduced 90.91%	20 $0
Q1 2022 May 04, 2022	SELL	$0.48 - $0.71 $3,111 - $4,602	-6,483 Reduced 96.72%	220 $0
Q3 2021 Nov 05, 2021	BUY	$1.01 - $1.25 $20 - $25	20 Added 0.3%	6,703 $6,000
Q1 2021 May 13, 2021	BUY	$1.3 - $2.35 $5,395 - $9,752	4,150 Added 163.84%	6,683 $9,000
Q4 2020 Feb 10, 2021	BUY	$0.8 - $2.16 $1,600 - $4,320	2,000 Added 375.23%	2,533 $3,000
Q3 2020 Nov 12, 2020	BUY	$0.86 - $2.36 $458 - $1,257	533 New	533 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.